
Healthcare / Medical Supplies · BSE
Founded in October 2007, Amkay Products Limited is a well-known name in India’s healthcare industry, manufacturing and supplying a wide range of medical products. Their offerings include medical devices like nebulizers and pulse oximeters, as well as disposable essentials such as face masks and alcohol swabs. Amkay’s 26,000 sq. ft. manufacturing facility in Thane, Maharashtra, is equipped with advanced machinery, a modern testing lab, and efficient handling equipment, ensuring smooth and high-quality production. The company’s strong focus on quality has earned it ISO 9001:2015 certification from QRO Certification LLP. As of December 31, 2023, Amkay employs 75 dedicated professionals, reflecting its commitment to building a skilled workforce. Despite the ever-changing healthcare landscape, the company remains focused on innovation, quality, and customer satisfaction, playing a key role in meeting healthcare needs across India.
Price Band
₹52 – ₹55
Issue Size
₹12.61 Cr
Lot Size
2000 shares
GMP
+112.7%
Est. Listing
₹117
at current GMP
Subscribed
748.11x
overall
Open
30 Apr 2024
Close
3 May 2024
Allotment
6 May 2024
Refund
7 May 2024
Demat Credit
8 May 2024
Listing
8 May 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹55
Band: ₹52 – ₹55
Estimated Listing Price
₹117
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,10,000
Estimated Profit / Lot
₹1,24,000
2000 × ₹62
Grey Market Premium trend
+₹62
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹62 | 112.7% | ₹117 |
| 30 Oct 2026 | +₹62 | 112.7% | ₹117 |
| 29 Oct 2026 | +₹56 | 101.5% | ₹111 |
GMP is unofficial market data. Not a guarantee of listing performance.
Amkay Products Limited is bringing an initial public offering (IPO) in the Healthcare / Medical Supplies sector with an aggregate issue size of ₹12.61 Crores. The shares are offered at a price band of ₹52 to ₹55 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-05-03, the basis of allotment is scheduled to be finalized on 2024-05-06. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
The latest grey market premium for Amkay Products Limited IPO is ₹62, which indicates an expected listing price of ₹117.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.